Skip to main content
. 2014 Nov 18;13:434. doi: 10.1186/1475-2875-13-434

Figure 5.

Figure 5

Pharmacological characterization of AgOAR45B mutants. A. Dose response curves of optopamine E161Q (closed triangles), E161A (open triangles), D100N (closed squares), D100A (open squares), D100N/E161Q (closed diamonds), and D100A/E161A (open diamonds) double mutants. B. Dose response curves of optopamine S206A (closed boxes), S210A (closed triangles) and S206A/S210A double mutants (open circles). The same control wild-type AgOAR45B (closed circles) data is presented in both A and B. Data are expressed as % 1 μM octopamine response. Means ± SD of three independent experiments are presented.